News and Trends 19 Dec 2018 Italian Biotech Raises Big Series A for ‘Gene Therapy 2.0’ …would be the first gene therapy to target a disease that is not caused by a single gene. “This opens the path to gene therapy 2.0, where the target includes… December 19, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 30 Dec 2020 A Look Back at the Past Decade of European Biotech …saw the US approval of Kymriah, the world’s first CAR-T cell therapy. This treatment consists of engineering the patient’s own immune cells to make them better at identifying and attacking… December 30, 2020 - 15 minutesmins - By Karen O’Hanlon Cohrt Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Oct 2017 Buongiorno Biotech! Top 4 Companies Making Milan Europe’s Next Biotech Hub …things Italian biotech, went as far as to tell me: “The aim should be to produce a few more ‘Genentas’.” The biotech takes on the immunosuppressive environment that a tumor… October 10, 2017 - 7 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 29 Jan 2025 Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic …is pancreatic cancer so difficult to treat and what drugs are currently in the therapeutic pipeline? Table of contents Why is pancreatic cancer so difficult to treat? There are several… January 29, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 13 Nov 2025 iGEM Jamboree: leap into the synthetic biology future …enzyme that breaks down plastics, in its apoplast. The apoplast is a network of plant cells that make up the cell walls, and so, the enzyme’s expression in these cells… November 13, 2025 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 7 Jun 2017 What Cancer Therapies did European Biotechs Showcase at ASCO 2017? …trial, planned to start later this year, that will test whether IO102, a peptide vaccine against the indoleamine 2,3-dioxygenase (IDO) enzyme, can boost the activity of an anti-PD1 checkpoint inhibitor… June 7, 2017 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 8 Nov 2022 Collaboration to develop CAR-T cell therapy for cutaneous T-cell lymphoma …treated are reprogrammed to bind specifically to the tumor cells expressing TAG-72. Upon infusion into the patient, the CTH-001 CAR-T cells are expected to destroy the CTCL-associated malignant T cells. … November 8, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 6 Nov 2018 Potential HIV Treatment Shows Early Stage Promise …the enzyme that HIV uses to insert viral DNA into the host cell’s genome. Integrase then inserts too much viral DNA into the cell, blowing the virus’s cover and making… November 6, 2018 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 23 Jul 2018 Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease …white blood cells and genetically engineering them to recognize cancer cells. The cells are then reintroduced into the patient, where they attack and kill cancer cells. While most CAR-T-cell therapy… July 23, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
In Depth 6 Nov 2024 Tuberculosis research: Are we finally close to developing a more effective treatment option? …when we have the tools to prevent it, detect it, and treat it,” WHO director-general Tedros Adhanom Ghebreyesus told reporters at the time the report was released. Having said that,… November 6, 2024 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 16 Sep 2024 Vironexis’ AAV vector approach: The next frontier in cancer immunology? …relatively straightforward: use AAV vectors to instruct the liver to secrete a therapeutic protein that guides T cells to recognize and attack cancer cells. This approach not only simplifies the… September 16, 2024 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jan 2023 Cartherics granted first patent in China …other immune cells. The company is also developing autologous CAR-T cell therapies. These use the patient’s own immune system T-cells, which are modified to be effective against the patient’s cancer… January 9, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email